CD Skripsi

Strategi Pt Bio Farma Indonesia Sebagai Center Of Excellent Dibidang Vaksin Dan Bio-Teknologi Dalam Organisasi Kerjasama Islam (Oki)

---

Bio Farma is a State-Owned Enterprise (BUMN) that produces vaccines
and antisera products owned by Indonesia which active as an International actor.
In 2017, Bio Farma was trusted by OIC to be the Center of Excellence on
Vaccines and Bio-technology Products, so as a leader in the development of
vaccine production for OIC members, Bio Farma needs to implement its strategy
in carrying out this role.
In discussing this research, the author uses qualitative research methods
with the perspective of neoliberalism and the state-level as the level of analysis
and is supported by the theory of International Cooperation and Competitive
Advantage to analyze the strategy for the research.
Research shows that Indonesia’s strategy by making Bio Farma active in
the development of vaccines production related activities in global market, is in
line with OIC Center of Excellence’s role and functions, which is the leader in
realizing the vision of to be self-reliance in vaccine production for OIC
members.Bio Farma as a company with competitive advantage implements
OICwork program based on Bio Farma’s strategy in increasing its
competitiveness by establishing cooperation through Reverse Linkage trilateral
partnership program, as well as knowledge sharing activities and forming
workshops that are beneficial for OIC members.
Keywords: Bio Farma, State-owned Enterprise, OIC Center of Excellence,
International Cooperation, Competitive Advantage

---

Ketersediaan

Informasi Detail

Judul Seri

-

No. Panggil

01 01.121 (0067)

Penerbit

Pekanbaru : Universitas Riau – FISIP - HUBUNGAN INTERNATIONAL., 2021

Deskripsi Fisik

x, 82 hlm.: ill.: 29 cm

Bahasa

Indonesia

ISBN/ISSN

-

Klasifikasi

01 01.121 (0067)

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

-

Edisi

-

Subjek

HUBUNGAN INTERNASIONAL

Info Detail Spesifik

-

Pernyataan Tanggungjawab

ELFITRA

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar